The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
Akechai Im-Aram(Seoul National University), Benjamin K. Tsang(University of Ottawa)
Cited by 34
Related Papers
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
|International Journal of Cancer|2007|185
Cisplatin Induces p53-Dependent FLICE-Like Inhibitory Protein Ubiquitination in Ovarian Cancer Cells
|Cancer Research|2008|85
P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism
|Oncogene|2011|84
Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance
|British Journal of Cancer|2008|74
Cell fate regulation by gelsolin in human gynecologic cancers
|Proceedings of the National Academy of Sciences|2014|62